Who Owns Accuray Company?

Accuray Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Accuray?

Understanding Accuray's ownership is key to grasping its market position and strategic path. Founded in 1990 by Dr. John R. Adler, Jr., the company went public in February 2007, shifting from private backing to public ownership.

Accuray, a leader in radiation oncology, offers advanced systems like the CyberKnife and TomoTherapy. As of August 21, 2025, its market capitalization stood at $170.09 million, with total net revenue of $458.5 million for the fiscal year ending June 30, 2025.

Accuray's ownership structure has evolved significantly since its inception. Initially a privately held entity, its transition to a publicly traded company on the NASDAQ Global Select Market under the ticker ARAY opened its shares to a wider investor base. This public status means that ownership is distributed among various shareholders, including institutional investors, mutual funds, and individual investors.

Institutional investors often hold substantial blocks of shares, influencing company decisions through their voting power. These can include large investment management firms and pension funds. The composition of these major shareholders can change over time, reflecting market dynamics and investment strategies. Understanding these shifts is crucial for assessing the company's governance and future direction. For a deeper look into the external factors affecting the company, consider an Accuray PESTEL Analysis.

Accuray Incorporated, originally established as NeuroControl Corporation in 1990, was founded by Dr. John R. Adler, Jr., a neurosurgeon from Stanford University. His vision was to revolutionize cancer treatment through robotic radiosurgery, leading to the development of the CyberKnife system. The company began its commercial operations in 1992.

Founding Vision

Dr. John R. Adler, Jr.'s primary goal was to advance cancer treatment methods through innovative robotic radiosurgery, a concept that drove the company's early development.

Early Operations

The company commenced its commercial activities in 1992, shortly after its rebranding from NeuroControl Corporation. This marked the beginning of bringing its advanced medical technology to market.

Initial Funding

While specific initial equity details are not public, early funding for Accuray likely came from venture capital and research grants, typical for the commercialization of cutting-edge medical technology.

Founder's Role

Dr. Adler's leadership was instrumental in shaping the company's strategic direction during its formative years. His expertise guided the development and market introduction of its core technologies.

Founder's Departure

Dr. Adler's tenure with the company concluded in 2010, described as a 'not-exactly-friendly departure.' Public records do not detail the specifics of any buyouts or disputes that occurred at that time.

Brand Evolution

Initially known as NeuroControl Corporation, the company underwent a rebranding in 1992 to Accuray Incorporated. This change coincided with the commercial launch of its innovative products.

The early ownership structure of Accuray Incorporated, established in 1990, is not fully detailed in public records. However, it is understood that the company's inception was driven by the vision of its founder, Dr. John R. Adler, Jr., a prominent neurosurgeon. The initial capital infusion for such a technologically advanced venture typically originates from venture capital firms and research grants, aimed at bringing groundbreaking medical innovations to market. Understanding the Competitors Landscape of Accuray can provide context for the market Accuray entered. Dr. Adler's departure in 2010 marked a significant transition, though the precise details of his exit and any associated ownership adjustments remain private.

Founding Details

Accuray was founded in 1990 by Dr. John R. Adler, Jr., with the initial name NeuroControl Corporation. The company's core mission was to innovate cancer treatment through robotic radiosurgery.

• Founded: 1990
• Founder: Dr. John R. Adler, Jr.
• Initial Name: NeuroControl Corporation
• Rebranded: 1992
• Key Technology: CyberKnife system

Accuray SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Accuray's ownership journey saw a significant shift with its initial public offering on February 8, 2007, pricing its shares at $18 and listing on the NASDAQ under ARAY. This event marked its transition to a publicly traded entity, with a substantial portion of shares sold by both the company and existing stockholders, fundamentally altering its corporate structure.

As of August 13, 2025, Accuray has 103 million shares outstanding, reflecting its status as a publicly traded company. The majority of its ownership, a substantial 78.02% as of July 30, 2025, is held by institutional investors. This high level of institutional backing suggests significant confidence from large investment firms in Accuray's business prospects. Key institutional shareholders as of June 30, 2025, include TCW Group Inc., BlackRock, Inc., Vanguard Group Inc., Neuberger Berman Group LLC, Heartland Advisors Inc., and Armistice Capital, Llc. Insiders, such as company executives and board members, hold a smaller stake of 2.26% as of July 30, 2025. Historically, the acquisition of TomoTherapy Inc. in 2011 for $277 million was a pivotal moment, broadening Accuray's product portfolio and impacting its corporate structure. Understanding Revenue Streams & Business Model of Accuray can provide further context to these ownership dynamics.

Accuray's Major Stakeholders

Institutional investors are the dominant force in Accuray's ownership structure, holding the vast majority of the company's shares.

• Institutional investors collectively own 78.02% of Accuray as of July 30, 2025.
• Key institutional investors include TCW Group Inc., BlackRock, Inc., and Vanguard Group Inc.
• Insider ownership stands at 2.26% as of July 30, 2025.
• The company went public on February 8, 2007, with shares trading on the NASDAQ under ARAY.
• Accuray had 103 million shares outstanding as of August 13, 2025.

Accuray PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Accuray company is governed by a Board of Directors comprising nine members, each serving staggered three-year terms to ensure consistent oversight. Joseph Whitters holds the position of Independent Chairman of the Board. The voting power for Accuray's common stock operates on a one-share-one-vote principle, with no provision for cumulative voting in director elections.

In terms of Accuray stock ownership, the corporate structure appears standard, with no dual-class shares or special voting rights reported. Insider transactions as of early 2025 indicate varied activity. Joseph Whitters, the Independent Chairman, demonstrated confidence in the company by purchasing shares valued at approximately US$156,000 within the preceding 12 months. Conversely, several key executives, including CEO Suzanne C. Winter and CFO Ali Pervaiz, along with other insiders like Gina Corradetti, Jesse Chew, Michael Hoge, and Patrick Spine, engaged in share sales over the 24 months leading up to 2025. This activity provides a snapshot of management's evolving stake in the company, which is crucial for understanding Accuray ownership dynamics.

Understanding Accuray's Shareholder Landscape

Accuray's governance is structured to balance leadership continuity with independent oversight. While specific details on founders' representation are not highlighted, the emphasis on independent directors is notable.

• The board has nine directors serving staggered three-year terms.
• Voting power is based on a one-share-one-vote system.
• Joseph Whitters is the Independent Chairman of the Board.
• Insider transactions show both share purchases and sales by management.
• The company's structure does not indicate dual-class shares or special voting rights.

For a deeper dive into the company's journey, explore the Brief History of Accuray.

Accuray Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Accuray Incorporated has undergone significant structural and leadership changes in recent years, impacting its ownership landscape. The company relocated its headquarters in August 2023 and experienced interim leadership changes in September 2024, alongside key operational appointments in early 2025. These developments are occurring within a context of evolving financial performance and market valuation.

Financially, Accuray reported total net revenue of $458.5 million for the fiscal year ended June 30, 2025, a 3 percent increase year-over-year. The company also reported a net loss of $1.6 million, a notable improvement from the $15.5 million net loss in fiscal year 2024. For fiscal year 2026, Accuray projects total net revenue between $471 million and $485 million. The company's order book-to-bill ratio stood at 1.2 for fiscal year 2025, indicating strong demand for its products.

Ownership Structure

Institutional investors hold a substantial portion of Accuray's stock, representing 78.02% as of July 30, 2025. Insider ownership accounts for 2.26%, providing insight into the Accuray company management ownership.

Market Performance and Valuation

Accuray's stock price experienced a decline of approximately 40.43% from August 19, 2024, to August 15, 2025. This led to a decrease in market capitalization from $199.10 million at the end of 2024 to $155.60 million by August 20, 2025.

Accuray Stock Ownership

The high institutional holding suggests that many Accuray major shareholders are investment funds and financial institutions. This ownership breakdown by institution is a key factor in understanding the company's financial dynamics and is a common characteristic of publicly traded companies, as Accuray Inc. is publicly traded.

Understanding Accuray's Corporate Structure

The current ownership trends, with significant institutional backing and minimal insider control, indicate a dispersed ownership structure. This aligns with the company's public trading status and its adherence to Accuray stock ownership regulations, reflecting its commitment to Mission, Vision & Core Values of Accuray.

Accuray Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔